Telix Pharmaceuticals | TLX - Ebit



Telix Pharmaceuticals reported AUD37.44M in EBIT for its fiscal semester ending in December of 2024.


Ebit Change Date
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Mayne Pharma AUD -16200000 13.2M Jun/2024
Medical Developments International AUD -12124000 3.97M Jun/2023
Mesoblast -31307000 3.82M Jun/2024
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Pacific Edge NZD -16918000 960K Mar/2024
Paradigm Biopharmaceuticals AUD -19930150 12.02M Jun/2023
Polynovo AUD 840K 147K Jun/2024
PYC Therapeutics AUD -25838000 3M Dec/2024
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
ResMed USD 456.57M 20.65M Jun/2025
Sonic Healthcare AUD 423.94M 80.3M Dec/2024